• Login
Redica Systems
  • For Pharma

    Our data generates critical pharma insights with our actionable data intelligence helping your team go from reactive to proactive.

    For MedTech

    Elevate your MedTech quality and regulatory strategies with our comprehensive intelligence solutions and unparalleled dataset.

  • Catalyst
  • About Us
    • People
    • Careers
    • Press
  • Resources

    View all Resources

    • Assessments
    • Reports
    • Webinars
    • Glossary
  • Blog
Request a Demo
Redica Systems
    • Redica Systems MedTech Intelligence
    • Redica Systems Pharma Intelligence
  • Catalyst
    • About Redica Systems
    • People
    • Careers
    • Press
  • Resources
  • Blog
Request a Demo
  • Login

Resources

Posted FDA 483 Violations | Week of 10/21/18

It’s violation study time, and our GMP expert has extracted the key documents from this week’s global headlines. To note is Operation Pangea XI as well as Europe’s multiple reports of GMP non-compliance. DRUGS: Cipla Limited received a 1-page, 2-observation 483 at the close of the inspection on September 28th 2018. Observations include:The commercial batch record […]

See You at ISPE in Philadelphia

November is right around the corner, and FDAzilla is starting it off right. We will be at the ISPE Annual Conference in Philadelphia! This conference & expo will not disappoint: there is a world-class speaker roster that covers the FDA and the CDER office. What is particularly exciting for us at FDAzilla are the speakers […]

37 New FDA 483s Added | October 29th 2018

In the past week, we added the following 483s to our database of 27,500+ FDA inspection documents. You can obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store. Can’t find the 483 you’re looking for? Here’s a FREE company report instead. [supsystic-tables id=30] Like this & want more? Sign up to get […]

Week of October 14th 2018 | FDA Sent These Warning Letters to Pharma Companies

FDA posted 6 warning letters this week including: 1 issued to a pharmaceutical company in South Korea1 issued to a clinical trial investigator in California BIORESEARCH MONITORING: Ignatius P Godoy, M.D. (Paramount, CA) receive a warning letter based on the outcome of a BIMO inspection for a clinical study ending June 8th, 2018. The study […]

How to Respond to FDA 483s

What does it even mean to officially respond to a 483 and, better yet, how can a 483 be avoided altogether? The answer is basically split into 3 parts: The Pre-ResponseThe Response ItselfThe Post-Response 1. The Pre-Response You can talk directly with the inspectors during and after the inspection to clarify points and understand their […]

3 Quick (but Proven) CMO Tips you Missed at the PDA Event

Every day I work with companies that are looking to find innovative solutions that mitigate compliance risk. Befriend the Invisible FDA Inspector (sort of) To start, I asked the crowd if anyone had a CMO get inspected and receive a 483, but the CMO didn’t tell them. Many hands shot up, and it’s no surprise. […]

41 New FDA 483s Added | October 22nd 2018

In the past week, we added the following 483s to our database of 27,500+ FDA inspection documents. You can obtain 483s, EIRs, InspectorProfiles, and more at the FDAzilla store. Can’t find the 483 you’re looking for? Here’s a FREE company report instead. [supsystic-tables id=27] Like this & want more? Sign up to get […]

Week of October 8th 2018 | FDA Sent These Warning Letters to Device Companies

FDA posted 6 warning letters this week including: 1 to a device manufacturer1 for seafood HACCP1 for food preparation3 for tobacco DEVICE: Becton Dickinson Medical Systems (Franklin Kales, NJ) received a warning letter on September 14th, 2018 based on the outcome of an inspection that lasted from May 16th, 2018 through August 1st, 2018 (yes).When […]

How the FDA and the 483 Have Changed

We asked our GMP Editor in Chief 3 important questions and got 3 insightful answers. Using decades worth of professional experience, she shares both the strengths and weaknesses of this thing we call the 483. What are 1 or 2 key ways you’ve seen the FDA change over the last 10 years? I think the […]

9 New Recalls | Week of October 8th 2018

From labels saying “you can take 4 pills” when it should really say “take 2” to injections with loose metal ferrules, here are last week’s recalls: An FDA update a day keeps the recalls away. Get free recall, 483, & Warning Letter reports. DRUG RECALLS: [supsystic-tables id=28] UNCLASSIFIED RECALLS: [supsystic-tables id=29] Like […]
« Older Entries
Newer Entries »
Company
  • About Redica Systems
  • People
  • Careers
  • Press
  • Contact Us
Catalyst
  • Redica Catalyst
  • Redica ID
  • Enrichment
  • Knowledge Graph
  • Redica Ontologies
Use Cases
  • For Pharma
  • For MedTech
  • Inspection Preparation
  • Vendor Quality
  • Regulatory Surveillance
Resources
  • Assessments
  • Reports
  • Webinars
  • Document Store
  • Blog
  • Glossary

© 2025 Redica. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
  • Status